Join to View Full Profile
1001 Calumet AveDyer, IN 46311
Phone+1 219-924-8178
Fax+1 219-924-8179
Dr. Tallarico is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2014 - 2017
Loyola University Medical CenterResidency, Internal Medicine, 2010 - 2013
University of Illinois College of MedicineClass of 2010
Certifications & Licensure
IN State Medical License 2017 - 2025
IL State Medical License 2010 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 10 citationsPembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.James Godfrey, Hongtao Liu, Jovian Yu, Michael Tallarico, Emily Curran
Blood Advances. 2023-03-28 - 6 citationsFrequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (allian...Michael Tallarico, Jared C. Foster, Drew K. Seisler, Jacqueline M. Lafky, Arti Hurria
Journal of Geriatric Oncology. 2018-04-17 - 54 citationsPredictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study.Narendranath Epperla, Mehdi Hamadani, Amanda F. Cashen, Kwang Woo Ahn, Eunhye Oak
Hematological Oncology. 2017-01-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
